Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 8
2012 10
2013 10
2014 4
2015 4
2016 4
2017 5
2018 2
2019 4
2020 1
2021 2
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial.
Sarris J, Byrne G, Castle D, Bousman C, Oliver G, Cribb L, Blair-West S, Brakoulias V, Camfield D, Ee C, Chamoli S, Boschen M, Dean OM, Dowling N, Menon R, Murphy J, Metri NJ, Nguyen TP, Wong A, Jordan R, Karamacoska D, Rossell SL, Berk M, Ng CH. Sarris J, et al. Among authors: camfield d. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Jul 13;117:110550. doi: 10.1016/j.pnpbp.2022.110550. Epub 2022 Mar 15. Prog Neuropsychopharmacol Biol Psychiatry. 2022. PMID: 35304155 Clinical Trial.
Treatment of refractory obsessive-compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study.
Sarris J, Byrne GJ, Oliver G, Cribb L, Blair-West S, Castle D, Dean OM, Camfield DA, Brakoulias V, Bousman C, Dowling N, Ee C, Murphy J, Menon R, Berk M, Chamoli S, Boschen M, Ng CH. Sarris J, et al. Among authors: camfield da. CNS Spectr. 2022 Oct;27(5):588-597. doi: 10.1017/S1092852921000638. Epub 2021 Jun 21. CNS Spectr. 2022. PMID: 34165060 Review.
Complementary Medicine for the Modification of Risk Factors for Cognitive Impairment.
Steiner GZ, Seto SW, Kwan YW, Haskell-Ramsay C, Camfield DA. Steiner GZ, et al. Among authors: camfield da. Evid Based Complement Alternat Med. 2017;2017:9472859. doi: 10.1155/2017/9472859. Epub 2017 Feb 19. Evid Based Complement Alternat Med. 2017. PMID: 28298937 Free PMC article. No abstract available.
The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial.
Russell SE, Skvarc DR, Mohebbi M, Camfield D, Byrne LK, Turner A, Ashton MM, Berk M, Dodd S, Malhi GS, Cotton SM, Bush AI, Dean OM. Russell SE, et al. Among authors: camfield d. Clin Psychopharmacol Neurosci. 2023 May 30;21(2):320-331. doi: 10.9758/cpn.2023.21.2.320. Clin Psychopharmacol Neurosci. 2023. PMID: 37119225 Free PMC article.
48 results